For any DOS 10/1/26 and thereafter the following oncology drug will require a prior authorization.
What is the new code?
- colony stimulating factor medication
- J2860- Injection, siltuximab, 10 mg
Which platform types does this change apply to?
- Commercial- all states
- Medicare Advantage- all states
- UHC commercial plans in the following states: New York, New Jersey, PA, TX, Arizona (does not include the full list) -please check with your UHC Community Plan that you accept.in your office/facility.
- UHC- exchange plans in the following states: New York, New Jersey, Alabama, FL, Colorado (does not include a full list) please check with the UHC individual exchange plan for your state.
Find this content useful? Follow me for more!
- Rhode Island Medicaid: update telehealth PT services
- Aetna Better Health NJ: new bundled oncology condition specific prior auth
- Aetna Better Health of NJ: Out of network provider reimbursement update
- Healthfirst PT/OT prior auth and coverage changes
- NYS Medicaid Prior authorization timeframe update- 1/1/27

Leave a comment